Enhancing Diagnostic Precision: Intracardiac Echocardiography-Guided Endomyocardial Biopsy for Complex Right Atrial Mass.

JACC Case Rep

Department of Cardiology, Centro Hospitalar Universitário Lisboa Norte,Centro Cardiovascular da Universidade de Lisboa (CCUL@RISE), Faculdade de Medicina da Universidade de Lisboa, Centro Académico de Medicina de Lisboa, Lisbon, Portugal.

Published: December 2024

An 80-year-old woman with a history of B-cell non-Hodgkin lymphoma presented to the emergency department with exertional dyspnea and lower limb edema. A transthoracic echocardiogram revealed a large extracardiac mass invading the right atrium. A diagnostic transcatheter endomyocardial biopsy guided by intracardiac echocardiography was performed. This case highlights the role of intracardiac echocardiography in enabling unusual endomyocardial biopsy targeting, allowing for correct positioning of the bioptome, adding to the procedure's safety and precision, mainly when performed on atrial masses.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11733991PMC
http://dx.doi.org/10.1016/j.jaccas.2024.102864DOI Listing

Publication Analysis

Top Keywords

endomyocardial biopsy
12
intracardiac echocardiography
8
enhancing diagnostic
4
diagnostic precision
4
precision intracardiac
4
intracardiac echocardiography-guided
4
echocardiography-guided endomyocardial
4
biopsy complex
4
complex atrial
4
atrial mass
4

Similar Publications

This case series highlights the role of endomyocardial biopsy (EMB) in diagnosing cardiac tumors instead of tumor resection. EMB provided critical diagnostic clarity and influenced therapeutic decisions, demonstrating its utility in complex cardiovascular cases while preventing unnecessary surgery. Furthermore, EMB provides vital information that can be used for a multidisciplinary approach to cardiac tumors.

View Article and Find Full Text PDF

Enhancing Diagnostic Precision: Intracardiac Echocardiography-Guided Endomyocardial Biopsy for Complex Right Atrial Mass.

JACC Case Rep

December 2024

Department of Cardiology, Centro Hospitalar Universitário Lisboa Norte,Centro Cardiovascular da Universidade de Lisboa (CCUL@RISE), Faculdade de Medicina da Universidade de Lisboa, Centro Académico de Medicina de Lisboa, Lisbon, Portugal.

An 80-year-old woman with a history of B-cell non-Hodgkin lymphoma presented to the emergency department with exertional dyspnea and lower limb edema. A transthoracic echocardiogram revealed a large extracardiac mass invading the right atrium. A diagnostic transcatheter endomyocardial biopsy guided by intracardiac echocardiography was performed.

View Article and Find Full Text PDF

Clinical Characteristics and Outcomes of Acute Myocarditis: An Analysis of Korean Multicenter Registry.

Korean Circ J

December 2024

Division of Cardiology, Department of Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

Background And Objectives: Data are limited on the clinical manifestations and outcomes of acute myocarditis from a large-scale registry. We investigated acute myocarditis's clinical characteristics and prognosis from a large-scale, multi-center registry in the Republic of Korea.

Methods: We collected data from seven hospitals between 2001 and 2021.

View Article and Find Full Text PDF

Endomyocardial biopsies (EMB) are invasive procedures performed in heart transplant (HTx) patients for surveillance of acute rejection. However, patient preferences for replacing EMBs with noninvasive assays in the context of potential institutional policy changes are unknown. A mixed-methods design was used with 28 semi-structured patient interviews and 123 self-administered online survey questionnaires in English and Spanish between January to June 2023.

View Article and Find Full Text PDF

Case report of entrectinib associated fulminant myocarditis.

Eur Heart J Case Rep

January 2025

Department of Cardiology, York Hospital, WellSpan Health, 30 Monument Rd, York, PA 17403, USA.

Background: ROS1 tyrosine kinase inhibitors are one of the primary immunotherapies for fusion-positive cancers. Tyrosine kinase inhibitors have markedly improved outcomes for advanced cancers previously with poor prognosis. Entrectinib is an example of an ROS1 inhibitor that can be used for lung adenocarcinoma.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!